{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:23:51Z","timestamp":1790987031101,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00277-021-04468-1","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T04:42:05Z","timestamp":1614832925000},"page":"1241-1249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Whole-body low-dose computed tomography (WBLDCT) in staging and re-staging of multiple myeloma"],"prefix":"10.1007","volume":"100","author":[{"given":"Davide","family":"Ippolito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Giandola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5742-802X","authenticated-orcid":false,"given":"Cesare","family":"Maino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pecorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ragusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gandola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cammillo Talei","family":"Franzesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Sironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"4468_CR1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/annonc\/mdi235","volume":"16","author":"E Terpos","year":"2005","unstructured":"Terpos E, Dimopoulos M-A (2005) Myeloma bone disease: pathophysiology and management. Ann Oncol 16:1223\u20131231. https:\/\/doi.org\/10.1093\/annonc\/mdi235","journal-title":"Ann Oncol"},{"key":"4468_CR2","doi-asserted-by":"publisher","unstructured":"Terpos E, Morgan G, Dimopoulos MA, et al. (2013) International Myeloma Working Group recommendations for the treatment of multiple myeloma\u2013related bone disease. JCO 31:2347\u20132357. doi:https:\/\/doi.org\/10.1200\/JCO.2012.47.7901","DOI":"10.1200\/JCO.2012.47.7901"},{"key":"4468_CR3","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1182\/blood-2018-08-825356","volume":"133","author":"E Zamagni","year":"2019","unstructured":"Zamagni E, Tacchetti P, Cavo M (2019) Imaging in multiple myeloma: how? When? Blood 133:644\u2013651. https:\/\/doi.org\/10.1182\/blood-2018-08-825356","journal-title":"Blood"},{"key":"4468_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/bjh.14827","volume":"178","author":"A Chantry","year":"2017","unstructured":"Chantry A, Kazmi M, Barrington S, Goh V, Mulholland N, Streetly M, Lai M, Pratt G, the British Society for Haematology Guidelines (2017) Guidelines for the use of imaging in the management of patients with myeloma. Br J Haematol 178:380\u2013393. https:\/\/doi.org\/10.1111\/bjh.14827","journal-title":"Br J Haematol"},{"key":"4468_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/ajh.21913","volume":"86","author":"SV Rajkumar","year":"2011","unstructured":"Rajkumar SV (2011) Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 86:57\u201365. https:\/\/doi.org\/10.1002\/ajh.21913","journal-title":"Am J Hematol"},{"key":"4468_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41408-018-0124-1","volume":"8","author":"LA Moulopoulos","year":"2018","unstructured":"Moulopoulos LA, Koutoulidis V, Hillengass J, Zamagni E, Aquerreta JD, Roche CL, Lentzsch S, Moreau P, Cavo M, Miguel JS, Dimopoulos MA, Rajkumar SV, Durie BGM, Terpos E, Delorme S (2018) Recommendations for acquisition, interpretation, and reporting of whole-body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group. Blood Cancer J 8:95. https:\/\/doi.org\/10.1038\/s41408-018-0124-1","journal-title":"Blood Cancer J"},{"key":"4468_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ejrad.2004.04.015","volume":"54","author":"M Horger","year":"2005","unstructured":"Horger M, Claussen CD, Bross-Bach U, Vonthein R, Trabold T, Heuschmid M, Pfannenberg C (2005) Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Eur J Radiol 54:289\u2013297. https:\/\/doi.org\/10.1016\/j.ejrad.2004.04.015","journal-title":"Eur J Radiol"},{"key":"4468_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00330-007-0738-3","volume":"18","author":"P Kr\u00f6pil","year":"2008","unstructured":"Kr\u00f6pil P, Fenk R, Fritz LB, Blondin D, Kobbe G, M\u00f6dder U, Cohnen M (2008) Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in the staging of multiple myeloma. Eur Radiol 18:51\u201358. https:\/\/doi.org\/10.1007\/s00330-007-0738-3","journal-title":"Eur Radiol"},{"key":"4468_CR9","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1148\/rg.2019180096","volume":"39","author":"AG Ormond Filho","year":"2019","unstructured":"Ormond Filho AG, Carneiro BC, Pastore D, Silva IP, Yamashita SR, Consolo FD, Hungria VTM, Sandes AF, Rizzatti EG, Nico MAC (2019) Whole-body imaging of multiple myeloma: diagnostic criteria. RadioGraphics 39:1077\u20131097. https:\/\/doi.org\/10.1148\/rg.2019180096","journal-title":"RadioGraphics"},{"key":"4468_CR10","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1182\/blood.V128.22.4468.4468","volume":"128","author":"J Hillengass","year":"2016","unstructured":"Hillengass J, Moulopoulos LA, Delorme S, Koutoulidis V, Hielscher T, Engelhart J, Drake MT, Rajkumar SV, Oestergaard B, Abildgaard N, Hinge M, Plesner T, Suehara Y, Matsue K, Caers J, Withofs N, Dimopoulos MA, Goldschmidt H, Lentzsch S, Durie BG, Terpos E (2016) Findings of whole-body computed tomography compared to conventional skeletal survey in patients with monoclonal plasma cell disorders-a study of the International Myeloma Working Group. Blood 128:4468","journal-title":"Blood"},{"key":"4468_CR11","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.3324\/haematol.2016.146092","volume":"101","author":"M Hinge","year":"2016","unstructured":"Hinge M, Andersen KT, Lund T, Jorgensen HB, Holdgaard PC, Ormstrup TE, Ostergaard LL, Plesner T (2016) Baseline bone involvement in multiple myeloma-a prospective comparison of conventional X-ray, low-dose computed tomography, and 18fluorodeoxyglucose positron emission tomography in previously untreated patients. Haematologica 101:e415\u2013e418","journal-title":"Haematologica"},{"key":"4468_CR12","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.ejrad.2014.02.008","volume":"83","author":"MB Wolf","year":"2014","unstructured":"Wolf MB, Murray F, Kilk K, Hillengass J, Delorme S, Heiss C, Neben K, Goldschmidt H, Kauczor HU, Weber MA (2014) Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolysis in patients with monoclonal plasma cell disease. Eur J Radiol 83:1222\u20131230. https:\/\/doi.org\/10.1016\/j.ejrad.2014.02.008","journal-title":"Eur J Radiol"},{"key":"4468_CR13","doi-asserted-by":"publisher","first-page":"E302","DOI":"10.1016\/S1470-2045(19)30309-2","volume":"6","author":"J Hillengass","year":"2019","unstructured":"Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, Joao C, Anderson KC, Garc\u00eda-Sanz R, Riva E, du J, van de Donk N, Berdeja JG, Terpos E, Zamagni E, Kyle RA, San Miguel J, Goldschmidt H, Giralt S, Kumar S, Raje N, Ludwig H, Ocio E, Schots R, Einsele H, Schjesvold F, Chen WM, Abildgaard N, Lipe BC, Dytfeld D, Wirk BM, Drake M, Cavo M, Lahuerta JJ, Lentzsch S (2019) International Myeloma Working Group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol 6:E302\u2013E312. https:\/\/doi.org\/10.1016\/S1470-2045(19)30309-2","journal-title":"Lancet Oncol"},{"key":"4468_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1148\/radiol.2483071964","volume":"248","author":"W Huda","year":"2008","unstructured":"Huda W, Ogden KM, Khorasani MR (2008) Converting dose-length product to effective dose at CT. Radiology 248:995\u20131003. https:\/\/doi.org\/10.1148\/radiol.2483071964","journal-title":"Radiology"},{"key":"4468_CR15","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1158\/1078-0432.CCR-14-1692","volume":"20","author":"MJ Pianko","year":"2014","unstructured":"Pianko MJ, Terpos E, Roodman GD, Divgi CR, Zweegman S, Hillengass J, Lentzsch S (2014) Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease. Clin Cancer Res 20:5888\u20135897. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1692","journal-title":"Clin Cancer Res"},{"key":"4468_CR16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.hoc.2016.03.007","volume":"30","author":"B Amos","year":"2016","unstructured":"Amos B, Agarwal A, Kanekar S (2016) Imaging of multiple myeloma. Hematol Oncol Clin North Am 30:843\u2013865. https:\/\/doi.org\/10.1016\/j.hoc.2016.03.007","journal-title":"Hematol Oncol Clin North Am"},{"key":"4468_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.12659\/PJR.901742","volume":"82","author":"R Chrzan","year":"2017","unstructured":"Chrzan R, Jurczyszyn A, Urbanik A (2017) Whole-body low-dose computed tomography (WBLDCT) in assessment of patients with multiple myeloma \u2013 pilot study and standard imaging protocol suggestion. Pol J Radiol 82:356\u2013363. https:\/\/doi.org\/10.12659\/PJR.901742","journal-title":"Pol J Radiol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04468-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04468-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04468-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T04:04:37Z","timestamp":1618286677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04468-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4468"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04468-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"assertion":[{"value":"30 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Local Ethical Committee\u2019s review of the protocol deemed that formal approval was not required owing to the retrospective, observational, and anonymous nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients signed the informed consent form to be eligible for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All patients gave consent for information about themselves to be published in scientific journals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}